# Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis

> **NCT00772304** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 102 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Olopatadine 0.6% / Azelastine 137 mcg

## Key facts

- **NCT ID:** NCT00772304
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772304, "Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00772304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*